- Chronic pancreatitis (CP) usually develops after recurrent episodes of acute pancreatitis in many but not all patients. CP can be asymptomatic until severe complications present.
- Typically middle-aged males.
- Most common cause is chronic alcohol use.
- Other etiologies/risks can be categorized by the TIGAR-O acronym:
- T – Toxic-Metabolic (smoking, hypercalcemia, hypertriglyceridemia, medications, toxins, CKD, DM)
- I – Idiopathic
- G – Genetic
- A – Autoimmune (type 1 and type 2)
- R – Recurrent acute or severe pancreatitis
- O – Obstructive (stones, calcifications, mass, stenosis, strictures, etc.)
- 20–25-year mortality rate of CP = 50%.
- Significant consequences including chronic pain, malnutrition, osteoporosis, diabetes mellitus (type 3c), and pancreatic cancer.
- Supportive care is the mainstay of treatment.
Clinical Signs and Symptoms
- Abdominal pain – epigastric, +/- radiation to back, worsened with food and alcohol, tender on exam.
- Jaundice – biliary obstruction or cirrhosis.
- Signs of endocrine and/or exocrine insufficiency:
- Glucose intolerance
- Malabsorption and weight loss
- Steatorrhea (fatty stools)
- Serum lipase
- Serum levels of pancreatic enzymes may not be elevated in CP due to loss of exocrine function.
- Liver function tests
- Elevated alkaline phosphatase, bilirubin and hepatic transaminases may suggest biliary tract obstruction or coexisting alcoholic liver disease.
- Serum calcium
- Serum albumin and protein
- Pancreatic function tests can be conducted as secondary/adjunctive testing. They are used primarily to diagnose exocrine pancreatic insufficiency (EPI) and have low sensitivity in the diagnosis of CP.
- CT or MRI are recommended as the first-line diagnostic tests.
- Possible CT findings: Dilated pancreatic ducts, atrophy, calcifications, complications (e.g. pseudocyst).
- Endoscopic US should be reserved for cases where MRI or CT is inconclusive.
- Transabdominal US may be used to look for complications or to rule out other conditions on the differential but is less useful that CT/MRI.
- Pancreatic calcification = pathognomonic of CP.
Potential Complications of CP
- Can lead to complications such as compression of the gastric outlet, duodenum, bile duct, and/or vessels; infection; bleeding; and fistulas.
- Can form secondary to pseudocysts or pancreatic surgery.
- Possible clinical features: abdominal pain, anemia, GI bleeding.
- Pancreatic fistulas
- Pancreatic ascites or pleural effusion
- Splenic vein thrombosis
- Can lead to variceal bleeding
- Bile duct obstruction
- Duodenal obstruction
- Pancreatogenic diabetes
- Exocrine pancreatic insufficiency (EPI)
- Pancreatic cancer
- Stepwise approach: NSAIDs and opiates should be avoided if possible.
- Inconclusive evidence for the role of antioxidants in improving pain in CP.
- Combinations of antioxidants may be more beneficial than monotherapy.
- Pancreatic enzyme therapy
- Evidence points to limited efficacy for improving primary pain in CP and therefore not suggested by the ACG. (Pancreatic enzyme therapy has an established role in the treatment of Exocrine Pancreatic Insufficiency).
Fluid and electrolyte correction
Potential Next Steps
- Most patients require admission.
- Referral to gastroenterology or surgery:
- Endoscopic decompressive therapy (ERCP/EUS) is performed in patients with symptomatic pancreatic duct obstruction.
- Surgical procedures to reduce pain may include decompression, resection or a combination. Surgical decompression may be considered if endoscopic drainage is unsuccessful in obstructive CP.
- Referral to pain management specialist.
- Alcohol and smoking cessation
- Nutrition replacement
- Interdisciplinary approach that incorporates behavioural interventions to help address impact on quality of life.
- No evidence to support pancreatic malignancy screening.
Quality Of Evidence?
We are highly confident that the true effect lies close to that of the estimate of the effect. There is a wide range of studies included in the analyses with no major limitations, there is little variation between studies, and the summary estimate has a narrow confidence interval.
We consider that the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. There are only a few studies and some have limitations but not major flaws, there are some variations between studies, or the confidence interval of the summary estimate is wide.
When the true effect may be substantially different from the estimate of the effect. The studies have major flaws, there is important variations between studies, of the confidence interval of the summary estimate is very wide.
ACG Clinical Guideline – recently published guideline (2020) based on a literature review of RCTs, meta-analyses and systematic reviews. See guideline for grading of individual recommendations, some of which are included in this summary.
Berkowitz R, Rose G. Pancreas. In: Walls RM, Hockberger RS, Gausche-Hill M, eds. Rosen’s Emergency Medicine: Concepts and Clinical Practice. 9th ed. Philadelphia, PA: Elsevier; 2018:1104-1111.e2. Accessed January 18, 2021.
Whitcomb DC; the North American Pancreatitis Study Group. Pancreatitis: TIGAR-O version 2 risk/etiology checklist with topic reviews, updates, and use primers. Clin Transl Gastroenterol. 2019;10(6):e00027.
Forsmark CE. Chronic Pancreatitis. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 11th ed. Philadelphia, PA: Elsevier; 2021:917-946.e8. Accessed March 10, 2021.
The purpose of this document is to provide health care professionals with key facts and recommendations for the diagnosis and treatment of patients in the emergency department. This summary was produced by the BC Emergency Medicine Network and uses the best available knowledge at the time of publication. However, healthcare professionals should continue to use their own judgment and take into consideration context, resources and other relevant factors. The BC Emergency Medicine Network is not liable for any damages, claims, liabilities, costs or obligations arising from the use of this document including loss or damages arising from any claims made by a third party. The BC Emergency Medicine Network also assumes no responsibility or liability for changes made to this document without its consent.
Last Updated Apr 16, 2021
Visit our website at https://www.bcemergencynetwork.ca
Add public comment…